Role for the Related Poly(ADP-Ribose) Polymerases Tankyrase 1 and 2 at Human Telomeres
Overview
Affiliations
Telomere maintenance is essential for the continuous growth of tumor cells. In most human tumors telomeres are maintained by telomerase, a specialized reverse transcriptase. Tankyrase 1, a human telomeric poly(ADP-ribose) polymerase (PARP), positively regulates telomere length through its interaction with TRF1, a telomeric DNA-binding protein. Tankyrase 1 ADP-ribosylates TRF1, inhibiting its binding to telomeric DNA. Overexpression of tankyrase 1 in the nucleus promotes telomere elongation, suggesting that tankyrase 1 regulates access of telomerase to the telomeric complex. The recent identification of a closely related homolog of tankyrase 1, tankyrase 2, opens the possibility for a second PARP at telomeres. We therefore sought to establish the role of tankyrase 1 at telomeres and to determine if tankyrase 2 might have a telomeric function. We show that endogenous tankyrase 1 is a component of the human telomeric complex. We demonstrate that telomere elongation by tankyrase 1 requires the catalytic activity of the PARP domain and does not occur in telomerase-negative primary human cells. To investigate a potential role for tankyrase 2 at telomeres, recombinant tankyrase 2 was subjected to an in vitro PARP assay. Tankyrase 2 poly(ADP-ribosyl)ated itself and TRF1. Overexpression of tankyrase 2 in the nucleus released endogenous TRF1 from telomeres. These findings establish tankyrase 2 as a bona fide PARP, with itself and TRF1 as acceptors of ADP-ribosylation, and suggest the possibility of a role for tankyrase 2 at telomeres.
Multiple E3 ligases control tankyrase stability and function.
Perrard J, Smith S Nat Commun. 2023; 14(1):7208.
PMID: 37938264 PMC: 10632493. DOI: 10.1038/s41467-023-42939-3.
TERRA R-loops connect and protect sister telomeres in mitosis.
Sze S, Bhardwaj A, Fnu P, Azarm K, Mund R, Ring K Cell Rep. 2023; 42(10):113235.
PMID: 37843976 PMC: 10873023. DOI: 10.1016/j.celrep.2023.113235.
Lovsund T, Mashayekhi F, Fitieh A, Stafford J, Ismail I Cells. 2023; 12(14).
PMID: 37508568 PMC: 10378431. DOI: 10.3390/cells12141904.
Tankyrase: a promising therapeutic target with pleiotropic action.
Sagathia V, Patel C, Beladiya J, Patel S, Sheth D, Shah G Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3363-3374.
PMID: 37338576 DOI: 10.1007/s00210-023-02576-5.
Sowa S, Bosetti C, Galera-Prat A, Johnson M, Lehtio L Biomolecules. 2022; 12(11).
PMID: 36421702 PMC: 9688111. DOI: 10.3390/biom12111688.